Efficacy of S-1 plus nedaplatin compared to standard second-line chemotherapy in EGFR-negative lung adenocarcinoma after failure of first-line chemotherapy
Crossref DOI link: https://doi.org/10.1007/s13277-014-2155-y
Published Online: 2014-06-05
Published Print: 2014-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Tang, Yu
Wang, Wei
Teng, Xiu-Zhi
Shi, Lin
Text and Data Mining valid from 2014-06-05
